Kidokoro M, Shida H
Vaccines (Basel). 2015; 2(4):755-71.
PMID: 26344890
PMC: 4494248.
DOI: 10.3390/vaccines2040755.
Sanchez-Sampedro L, Perdiguero B, Mejias-Perez E, Garcia-Arriaza J, Di Pilato M, Esteban M
Viruses. 2015; 7(4):1726-803.
PMID: 25853483
PMC: 4411676.
DOI: 10.3390/v7041726.
Mackett M
World J Microbiol Biotechnol. 2014; 7(2):137-49.
PMID: 24424925
DOI: 10.1007/BF00328983.
Walsh S, Dolin R
Expert Rev Vaccines. 2011; 10(8):1221-40.
PMID: 21854314
PMC: 3223417.
DOI: 10.1586/erv.11.79.
Golden J, Hooper J
Expert Rev Vaccines. 2011; 10(7):1021-35.
PMID: 21806397
PMC: 9491137.
DOI: 10.1586/erv.11.46.
LC16m8: an attenuated smallpox vaccine.
Kenner J, Cameron F, Empig C, Jobes D, Gurwith M
Vaccine. 2006; 24(47-48):7009-22.
PMID: 17052815
PMC: 7115618.
DOI: 10.1016/j.vaccine.2006.03.087.
Genetically stable and fully effective smallpox vaccine strain constructed from highly attenuated vaccinia LC16m8.
Kidokoro M, Tashiro M, Shida H
Proc Natl Acad Sci U S A. 2005; 102(11):4152-7.
PMID: 15753319
PMC: 554788.
DOI: 10.1073/pnas.0406671102.
Modified vaccinia virus Ankara immunization protects against lethal challenge with recombinant vaccinia virus expressing murine interleukin-4.
McCurdy L, Rutigliano J, Johnson T, Chen M, Graham B
J Virol. 2004; 78(22):12471-9.
PMID: 15507634
PMC: 525045.
DOI: 10.1128/JVI.78.22.12471-12479.2004.
Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses.
Belyakov I, Earl P, Dzutsev A, Kuznetsov V, Lemon M, Wyatt L
Proc Natl Acad Sci U S A. 2003; 100(16):9458-63.
PMID: 12869693
PMC: 170940.
DOI: 10.1073/pnas.1233578100.
Immunogenicity and safety of defective vaccinia virus lister: comparison with modified vaccinia virus Ankara.
Ober B, Bruhl P, Schmidt M, Wieser V, Gritschenberger W, Coulibaly S
J Virol. 2002; 76(15):7713-23.
PMID: 12097585
PMC: 136372.
DOI: 10.1128/jvi.76.15.7713-7723.2002.
Multi-envelope HIV vaccine safety and immunogenicity in small animals and chimpanzees.
Lockey T, Slobod K, Caver T, DCosta S, Owens R, McClure H
Immunol Res. 2000; 21(1):7-21.
PMID: 10803879
DOI: 10.1385/IR:21:1:7.
Evaluation of the thymidine kinase (tk) locus as an insertion site in the highly attenuated vaccinia MVA strain.
Scheiflinger F, Falkner F, Dorner F
Arch Virol. 1996; 141(3-4):663-9.
PMID: 8645102
DOI: 10.1007/BF01718324.
Virion polypeptides of poxviruses.
Arita M, TAGAYA I
Arch Virol. 1980; 63(3-4):209-25.
PMID: 6243923
DOI: 10.1007/BF01315028.
Comparison of direct and indirect solid-phase microradioimmunoassays for the detection of viral antigens and antiviral antibody.
Rosenthal J, Hayashi K, Notkins A
Appl Microbiol. 1973; 25(4):567-73.
PMID: 4349247
PMC: 380863.
DOI: 10.1128/am.25.4.567-573.1973.
In vitro stimulation of sensitized lymphocytes by herpes simplex virus and vaccinia virus.
Rosenberg G, Farber P, Notkins A
Proc Natl Acad Sci U S A. 1972; 69(3):756-60.
PMID: 4335071
PMC: 426551.
DOI: 10.1073/pnas.69.3.756.
Vaccinia virus strain differences. I. Neutralization of vaccinia virus strains by homologous and heterologous antisera.
Dunlap R, Barker L
Arch Gesamte Virusforsch. 1973; 42(2):107-16.
PMID: 4126981
Immunization today--a review.
Marks M, Brazeau M, Shapera R
Can Med Assoc J. 1973; 108(11):1413-8.
PMID: 4123496
PMC: 1941520.
Molecular attenuation of vaccinia virus: mutant generation and animal characterization.
Lee M, Roos J, McGuigan L, Smith K, Cormier N, Cohen L
J Virol. 1992; 66(5):2617-30.
PMID: 1560521
PMC: 241015.
DOI: 10.1128/JVI.66.5.2617-2630.1992.
